Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Synchron announced today that it raised $200 million in a Series D financing round to support the commercialization of its ...

Precision Neuroscience’s brain-computer interface—a wireless device that aims to restore function to people with paralysis—is ...

Precision Neuroscience announced today that it received an investment from SCI Ventures, a specialist venture fund focused on ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

The MarketWatch News Department was not involved in the creation of this content. XIAMEN, China, July 18, 2025 /PRNewswire/ -- Brain-Computer Interface (BCI) technology is redefining human-machine ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

Imagine being able to compose an email or steer a wheelchair directly with your thoughts. For millions of people living with neurological disorders such as ALS, this possibility could be life-changing ...

Brain-computer interface (BCI) technology creates a direct link between the brain’s electrical activity and a digital device. This connection can bring a vast range of benefits in assisting, ...